FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3214308746> ?p ?o ?g. }

• W3214308746 endingPage "139" @default.
• W3214308746 startingPage "123" @default.
• W3214308746 abstract "Neuroblastoma (NB) represents the most common extracranial tumor of childhood. Prognosis is quite variable, ranging from spontaneous regression to aggressive behavior with wide metastatization, high mortality, and limited therapeutic options. Radiotheranostics combines a radiopharmaceutical pair in a unique approach, suitable both for diagnosis and therapy. For many years, metaiodobenzylguanidine (MIBG), labeled with 123I for imaging or 131I for therapy, has represented the main theranostic agent in NB, since up to 90% of NB incorporates the aforementioned radiopharmaceutical. In recent years, novel theranostic agents hold promise in moving the field of NB radiotheranostics forward. In particular, SarTATE, consisting of octreotate targeting somatostatin receptors, has been applied with encouraging results, with 64Cu-SARTATE being used for disease detection and with 67Cu-SARTATE being used for therapy. Furthermore, recent evidence has highlighted the potential of targeted alpha therapy (TAT) for treating cancer by virtue of alpha particles’ high ionizing density and high probability of killing cells along their track. On this path, 211At-astatobenzylguanidine (MABG) has been developed as a potential agent for TAT and is actually under evaluation in preclinical NB models. In this review, we performed a web-based and desktop literature research concerning radiotheranostic approaches in NB, covering both the radiopharmaceuticals already implemented in clinical practice (i.e.,123/1311-MIBG) and those still in a preliminary or preclinical phase." @default.
• W3214308746 created "2021-11-22" @default.
• W3214308746 creator A5000142286 @default.
• W3214308746 creator A5018933113 @default.
• W3214308746 creator A5019371574 @default.
• W3214308746 creator A5033637751 @default.
• W3214308746 creator A5044034969 @default.
• W3214308746 creator A5049968775 @default.
• W3214308746 creator A5069997978 @default.
• W3214308746 creator A5082693213 @default.
• W3214308746 creator A5083605890 @default.
• W3214308746 date "2021-11-10" @default.
• W3214308746 modified "2023-09-26" @default.
• W3214308746 title "Radiotheranostic Agents Targeting Neuroblastoma: State-of-the-Art and Emerging Perspectives" @default.
• W3214308746 cites W1980767539 @default.
• W3214308746 cites W1988750891 @default.
• W3214308746 cites W1991115767 @default.
• W3214308746 cites W1991363321 @default.
• W3214308746 cites W2010978319 @default.
• W3214308746 cites W2011795445 @default.
• W3214308746 cites W2015321769 @default.
• W3214308746 cites W2034721431 @default.
• W3214308746 cites W2037479586 @default.
• W3214308746 cites W2046180004 @default.
• W3214308746 cites W2049600470 @default.
• W3214308746 cites W2054524692 @default.
• W3214308746 cites W2062811495 @default.
• W3214308746 cites W2091630347 @default.
• W3214308746 cites W2101362713 @default.
• W3214308746 cites W2102640940 @default.
• W3214308746 cites W2111733282 @default.
• W3214308746 cites W2130925781 @default.
• W3214308746 cites W2134257528 @default.
• W3214308746 cites W2138655697 @default.
• W3214308746 cites W2151845120 @default.
• W3214308746 cites W2165205961 @default.
• W3214308746 cites W2233302010 @default.
• W3214308746 cites W2320805560 @default.
• W3214308746 cites W2326620024 @default.
• W3214308746 cites W2400681987 @default.
• W3214308746 cites W2407688877 @default.
• W3214308746 cites W2410318866 @default.
• W3214308746 cites W2573369749 @default.
• W3214308746 cites W2774327887 @default.
• W3214308746 cites W2891439551 @default.
• W3214308746 cites W2900489991 @default.
• W3214308746 cites W2908784320 @default.
• W3214308746 cites W2915052615 @default.
• W3214308746 cites W2944746103 @default.
• W3214308746 cites W2970830887 @default.
• W3214308746 cites W2980942118 @default.
• W3214308746 cites W3024597853 @default.
• W3214308746 cites W3025274926 @default.
• W3214308746 cites W3088706923 @default.
• W3214308746 cites W3130290792 @default.
• W3214308746 cites W3140948861 @default.
• W3214308746 cites W3151194432 @default.
• W3214308746 cites W3164107635 @default.
• W3214308746 cites W3164753345 @default.
• W3214308746 cites W4211031423 @default.
• W3214308746 cites W84978199 @default.
• W3214308746 doi "https://doi.org/10.3390/onco1020011" @default.
• W3214308746 hasPublicationYear "2021" @default.
• W3214308746 type Work @default.
• W3214308746 sameAs 3214308746 @default.
• W3214308746 citedByCount "0" @default.
• W3214308746 crossrefType "journal-article" @default.
• W3214308746 hasAuthorship W3214308746A5000142286 @default.
• W3214308746 hasAuthorship W3214308746A5018933113 @default.
• W3214308746 hasAuthorship W3214308746A5019371574 @default.
• W3214308746 hasAuthorship W3214308746A5033637751 @default.
• W3214308746 hasAuthorship W3214308746A5044034969 @default.
• W3214308746 hasAuthorship W3214308746A5049968775 @default.
• W3214308746 hasAuthorship W3214308746A5069997978 @default.
• W3214308746 hasAuthorship W3214308746A5082693213 @default.
• W3214308746 hasAuthorship W3214308746A5083605890 @default.
• W3214308746 hasBestOaLocation W32143087461 @default.
• W3214308746 hasConcept C126322002 @default.
• W3214308746 hasConcept C143998085 @default.
• W3214308746 hasConcept C2776715637 @default.
• W3214308746 hasConcept C502942594 @default.
• W3214308746 hasConcept C509974204 @default.
• W3214308746 hasConcept C54355233 @default.
• W3214308746 hasConcept C71924100 @default.
• W3214308746 hasConcept C81885089 @default.
• W3214308746 hasConcept C86803240 @default.
• W3214308746 hasConceptScore W3214308746C126322002 @default.
• W3214308746 hasConceptScore W3214308746C143998085 @default.
• W3214308746 hasConceptScore W3214308746C2776715637 @default.
• W3214308746 hasConceptScore W3214308746C502942594 @default.
• W3214308746 hasConceptScore W3214308746C509974204 @default.
• W3214308746 hasConceptScore W3214308746C54355233 @default.
• W3214308746 hasConceptScore W3214308746C71924100 @default.
• W3214308746 hasConceptScore W3214308746C81885089 @default.
• W3214308746 hasConceptScore W3214308746C86803240 @default.
• W3214308746 hasIssue "2" @default.
• W3214308746 hasLocation W32143087461 @default.
• W3214308746 hasLocation W32143087462 @default.

• next